Interventional Cardiology Devices And Equipment Market Analysis 2024-2033 : Forecast Market Size, Top Segments And Largest Region | GE Healthcare, Abbott Laboratories, Boston Scientific Corporation

"The interventional cardiology devices and equipment market size has grown strongly in recent years. It will grow from $14.1 billion in 2023 to $15.48 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to cardiovascular disease prevalence, aging population, patient demand for minimally invasive procedures, clinical guidelines and research.

The interventional cardiology devices and equipment market size is expected to see strong growth in the next few years. It will grow to $21.73 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to personalized medicine, telehealth integration, global access to healthcare, robot-assisted interventions. Major trends in the forecast period include advanced imaging technologies, artificial intelligence (ai) in interventional cardiology, complex lesion treatments, next-generation drug-eluting stents (des).

Market Overview -
Interventional cardiology devices and equipment are used in interventional cardiology, a branch of medicine that deals with the catheter-based treatment of structural heart diseases.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=2444&type=smp

Rising Prevalence Of Cardiovascular Diseases Fuels Growth In The Interventional Cardiology Devices And Equipment Market
The interventional cardiology devices and equipment market is being driven by an increase in cardiovascular diseases. Cardiovascular diseases are health problems that are associated with the blood vessels, circulatory system as well as heart. The rise in cardiovascular diseases has led to a rise in healthcare expenditure in the medical equipment market which further drives the interventional cardiac devices and equipment market. According to an estimate by Centers for Disease Control and Prevention (CDC), heart diseases caused 697,000 deaths in 2020. Further, according to an estimate by WHO, cardiovascular diseases are expected to account for 23.6 million deaths by 2030.

Competitive Landscape -
Major companies operating in the interventional cardiology devices and equipment market include GE Healthcare, Abbott Laboratories, Boston Scientific Corporation, Medtronic Inc., Johnson & Johnson, B. Braun Melsungen AG, Biosensors International Ltd, Novacam Technologies Inc., Cook Medical LLC, Biotronik SE & Co. KG, ACIST Medical Systems Inc., Cordis Corporation, Terumo Corporation, Edward Lifesciences Corporation, Cardinal Health Inc., iVascular GmbH, Becton Dickinson and Company, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Asahi Intecc Co. Ltd., AngioDynamics, C. R. Bard Inc., Endologix Inc., Lombard Medical Limited, Spectranetics Corporation, Vascular Solutions Inc., W. L. Gore & Associates Inc., Cardiva Medical Inc., Cardiovascular Systems Inc., ClearStream Technologies Ltd., Contego Medical LLC, Shockwave Medical Inc.

Technological Advancements Transforming The Interventional Cardiology Devices Market
Advancement in the technology of Interventional cardiology devices is one of the major trends in the market. Advanced devices cover technologically advanced imaging modalities such as Intravenous Ultrasound (IVUS), Fractional Flow Reserve (FFR), and Optical Coherence Tomography (OCT). For instance, according to a study published by the US CDC (Centers for Disease Control and Prevention), the treatment of cardiovascular diseases has changed substantially due to the introduction of new drug therapies and devices such as guidewires and stents which allow the patient to live quality and longer lives.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/interventional-cardiology-devices-and-equipment-global-market-report

Key Segments -
The interventional cardiology devices and equipment market covered in this report is segmented -
1) By Type: Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Other Interventional Cardiology Devices
2) By Age Group: New-born (0-30 days), Infant (31 days-1 year), Children (1-18 years), Adult (18+ years)
3) By Application: Hospitals, Clinics, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.